Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Dexter, David T.
Jenner, Peter
Schapira, Anthony H. V.
and
Marsden, C. David
1992.
Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia.
Annals of Neurology,
Vol. 32,
Issue. S1,
p.
S94.
Jenner, P.
1993.
Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease.
Acta Neurologica Scandinavica,
Vol. 87,
Issue. S146,
p.
6.
Götz, Mario E.
Künig, Gabriella
Riederer, Peter
and
Youdim, Moussa B.H.
1994.
Oxidative stress: Free radical production in neural degeneration.
Pharmacology & Therapeutics,
Vol. 63,
Issue. 1,
p.
37.
Jenner, P.
and
Olanow, C.W.
1996.
Neurodegeneration and Neuroprotection in Parkinson's Disease.
p.
23.
Götz, Mario E.
Künig, Gabriella
Riederer, Peter
and
Youdim, Moussa B.H.
1996.
Chemical Factors in Neural Growth, Degeneration and Repair.
p.
425.
Kotze, Maritha J.
de Villiers, J.Nico P.
Rooney, Roberta N.
Grobbelaar, Johanna J.
Mansvelt, Erna P.G.
Bouwens, Christianne S.H.
Carr, Jonathan
Stander, Ilse
and
du Plessis, Lana
2001.
Analysis of the NRAMP1 Gene Implicated in Iron Transport: Association with Multiple Sclerosis and Age Effects.
Blood Cells, Molecules, and Diseases,
Vol. 27,
Issue. 1,
p.
44.
Corsini, G. U.
Maggio, R.
and
Vaglini, F.
2002.
Dopamine in the CNS II.
Vol. 154 / 2,
Issue. ,
p.
321.
Chakrabarty, A
Emerson, M R
and
LeVine, S M
2003.
Hemeoxygenase-1 in SJL mice with experimental allergic encephalomyelitis.
Multiple Sclerosis Journal,
Vol. 9,
Issue. 4,
p.
372.
Jenner, Peter
2003.
Oxidative stress in Parkinson's disease.
Annals of Neurology,
Vol. 53,
Issue. S3,
p.
S26.
Sfagos, Constantinos
Makis, Alexandros C
Chaidos, Aristeidis
Hatzimichael, Eleftheria C
Dalamaga, Androniki
Kosma, Katerina
and
Bourantas, Konstantinos L.
2005.
Serum ferritin, transferrin and soluble transferrin receptor levels in multiple sclerosis patients.
Multiple Sclerosis Journal,
Vol. 11,
Issue. 3,
p.
272.
Ristić, Smiljana
Lovrečić, Luca
Brajenović-Milić, Bojana
Starčević-Čizmarević, Nada
Jazbec, Saša Šega
Sepčić, Juraj
Kapović, Miljenko
and
Peterlin, Borut
2005.
Mutations in the hemochromatosis gene (HFE) and multiple sclerosis.
Neuroscience Letters,
Vol. 383,
Issue. 3,
p.
301.
Kotze, Maritha J.
de Villiers, J Nico P
Warnich, Louise
Schmidt, Stephen
Carr, Jonathan
Mansvelt, Erna
Fourie, Elba
and
van Rensburg, Susan J
2006.
Lack of clinical manifestation of hereditary haemochromatosis in South African patients with multiple sclerosis.
Metabolic Brain Disease,
Vol. 21,
Issue. 2-3,
p.
105.
van Rensburg, S. J.
Kotze, M. J.
Hon, D.
Haug, P.
Kuyler, J.
Hendricks, M.
Botha, J.
Potocnik, F. C. V.
Matsha, T.
and
Erasmus, R. T.
2006.
Iron and the folate-vitamin B12-methylation pathway in multiple sclerosis.
Metabolic Brain Disease,
Vol. 21,
Issue. 2-3,
p.
117.
Ramagopalan, Sreeram V.
Cukjati, Marko
Černilec, Maja
DeLuca, Gabriele C.
Dyment, David A.
Degenhardt, Alexandra
Sadovnick, A. Dessa
Šerbec, Vladka Čurin
Ebers, George C.
and
Duquette, Pierre
2008.
Mutations in the hemochromatosis gene and the clinical outcome of multiple sclerosis.
Journal of Neuroimmunology,
Vol. 203,
Issue. 1,
p.
104.
Gellein, Kristin
Skogholt, Jon H.
Aaseth, Jan
Thoresen, Gunnar B.
Lierhagen, Syverin
Steinnes, Eiliv
Syversen, Tore
and
Flaten, Trond Peder
2008.
Trace elements in cerebrospinal fluid and blood from patients with a rare progressive central and peripheral demyelinating disease.
Journal of the Neurological Sciences,
Vol. 266,
Issue. 1-2,
p.
70.
O'Brien, Bronwyn A.
Archer, Nicholas S.
Simpson, Ann M.
Torpy, Fraser R.
and
Nassif, Najah T.
2008.
Association of SLC11A1 promoter polymorphisms with the incidence of autoimmune and inflammatory diseases: A meta-analysis.
Journal of Autoimmunity,
Vol. 31,
Issue. 1,
p.
42.
Kell, Douglas B
2009.
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.
BMC Medical Genomics,
Vol. 2,
Issue. 1,
Zivadinov, Robert
Brown, Mari Heininen-
Schirda, Claudiu V.
Poloni, Guy U.
Bergsland, Niels
Magnano, Christopher R.
Durfee, Jacqueline
Kennedy, Cheryl
Carl, Ellen
Hagemeier, Jesper
Benedict, Ralph H.B.
Weinstock-Guttman, Bianca
and
Dwyer, Michael G.
2012.
Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis.
NeuroImage,
Vol. 59,
Issue. 1,
p.
331.
Zhang, Lei
Hong, Zhongsi
Chen, Xiaoyu
Tan, Sha
Lin, Yinyao
Wang, Yanqiang
Sun, Shaoyang
Cai, Wei
and
Lu, Zhengqi
2014.
Iron Metabolism in Neuromyelitis Optica Patients.
Journal of the Neurological Sciences,
Vol. 347,
Issue. 1-2,
p.
214.
Crielaard, Bart J.
Lammers, Twan
and
Rivella, Stefano
2017.
Targeting iron metabolism in drug discovery and delivery.
Nature Reviews Drug Discovery,
Vol. 16,
Issue. 6,
p.
400.